AP
SNDX icon

Americana Partners’s Syndax Pharmaceuticals SNDX Stock Holding History

Americana Partners’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-800
Closed -$7K – 422
2019
Q4 		$7K Buy
+800
New +$5.88K ﹤0.01% 467

Other funds holding SNDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Americana Partners's SNDX Position: Q1 2020 in Review

Americana Partners sold out of Syndax Pharmaceuticals (SNDX) in Q1 2020, closing a stake of 800 shares — an estimated $7K sold.

Americana Partners first reported a position in SNDX in Q4 2019 and held it in 1 quarter. The position peaked at $7K in Q4 2019. 83 funds tracked by Wall St. Rank hold SNDX as of Q1 2020.

  • Americana Partners reported no remaining Syndax Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Americana Partners sold 800 Syndax Pharmaceuticals shares in Q1 2020, an estimated $7K.
  • Americana Partners first reported a position in Syndax Pharmaceuticals in Q4 2019 and held it in 1 quarter.
  • Americana Partners's Syndax Pharmaceuticals position peaked at $7K in Q4 2019.
  • 83 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2020.

Based on Americana Partners's 13F filing for Q1 2020, filed 12 May 2020.